Back
Tralucent Global Alt(long/Shrt) Eq E ETF Vs. Avidity Biosciences Industry Stock Comparison
Sell
27
TGAF.TO
Tralucent Global Alt(long/Shrt) Eq E ETF
Last Price:
22.16
Seasonality Move:
--
Sell
28
RNA
Avidity Biosciences
Last Price:
45.91
Seasonality Move:
16.42%
Sell
27
Tralucent Global Alt(long/Shrt) Eq E ETF (TGAF.TO)
is a Sell
Is Tralucent Global Alt(long/Shrt) Eq E ETF a Buy, Sell or Hold?
- The current Tralucent Global Alt(long/Shrt) Eq E ETF [TGAF.TO] share price is $22.16. The Score for TGAF.TO is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
- TGAF.TO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
28
Avidity Biosciences (RNA)
is a Sell
Is Avidity Biosciences a Buy, Sell or Hold?
- The current Avidity Biosciences [RNA] share price is $45.93. The Score for RNA is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
- RNA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
TGAF.TO Stock Price Chart
What is Tralucent Global Alt(long/Shrt) Eq E ETF's stock price today?
-
The Tralucent Global Alt(long/Shrt) Eq E ETF share price today is $22.16
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TGAF.TO is experiencing buying pressure, which is a positive indicator for future bullish movement.
RNA Stock Price Chart
What is Avidity Biosciences's stock price today?
-
The Avidity Biosciences share price today is $45.93
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RNA is experiencing buying pressure, which is a positive indicator for future bullish movement.
TGAF.TO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.18 | Buy |
Relative Strength Index (14 RSI): | 65.74 | Buy |
Chaikin Money Flow: | 300 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (21.39 - 22.05) | Buy |
Bollinger Bands (100): | (20.93 - 21.85) | Buy |
RNA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.39 | Buy |
Relative Strength Index (14 RSI): | 57.88 | Buy |
Chaikin Money Flow: | 938459 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (41.07 - 44.51) | Buy |
Bollinger Bands (100): | (32.26 - 46) | Buy |
TGAF.TO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 22.06 | Buy |
20-day SMA: | 21.73 | Buy |
50-day SMA: | 21.59 | Buy |
200-day SMA: | 20.65 | Buy |
8-day EMA: | 22.06 | Buy |
20-day EMA: | 21.86 | Buy |
50-day EMA: | 21.64 | Buy |
200-day EMA: | 20.62 | Buy |
RNA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 44.25 | Buy |
20-day SMA: | 42.58 | Buy |
50-day SMA: | 43.66 | Buy |
200-day SMA: | 28.23 | Buy |
8-day EMA: | 43.92 | Buy |
20-day EMA: | 43.38 | Buy |
50-day EMA: | 42.37 | Buy |
200-day EMA: | 31.41 | Buy |
Tralucent Global Alt(long/Shrt) Eq E ETF Earnings Growth & TGAF.TO Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Avidity Biosciences Earnings Growth & RNA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.15 per share, and a decrease next year of $0.20 per share.
Tralucent Global Alt(long/Shrt) Eq E ETF Technical Analysis
Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | 30 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Avidity Biosciences Technical Analysis
Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | 30 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |